After identifying recent federal efforts that would require drug pricing transparency, this article discusses two state laws enacted recently. Thereafter, the article assesses previously enacted state laws requiring drug manufacturers to disclose pricing and other information to determine whether these reporting requirements have had any effect on drug pricing in the applicable state.

Originally published in Pratt’s Government Contracting Law Report - July 2019.